Related Experiment Videos
Murine natural killer cells limit coxsackievirus B3 replication
Journal of Immunology (Baltimore, Md. : 1950)
|August 1, 1987
Summary
Natural killer (NK) cells directly limit coxsackievirus B3 replication in myocarditis. These immune cells kill virus-infected cells, reducing viral loads both in vitro and in vivo.
Area of Science:
- Immunology
- Virology
- Cardiology
Background:
- Previous studies suggested natural killer (NK) cells limit coxsackievirus B3 (CVB3m) replication in myocarditis.
- Direct evidence for NK cell antiviral activity in CVB3m infection was lacking.
Purpose of the Study:
- To provide direct evidence that NK cells limit CVB3m replication.
- To investigate the mechanism of NK cell-mediated antiviral activity against CVB3m.
Main Methods:
- In vitro experiments using primary murine neonatal skin fibroblast (MNSF) cultures and splenic large granular lymphocytes (LGL).
- In vivo experiments using a mouse model of CVB3m myocarditis.
- Utilized complement-mediated lysis with anti-asialo GM1 antiserum and anti-Lyt-2 monoclonal antibody to assess NK cell involvement.
Main Results:
- Activated LGL (NK cells) reduced CVB3m titers in MNSF cultures.
- Antiviral effect was abrogated by anti-asialo GM1 antiserum, indicating NK cell specificity.
- NK cells specifically lysed CVB3m-infected MNSF, not uninfected cells or cells with UV-inactivated virus.
- Mice treated with LGL showed reduced heart viral titers after CVB3m challenge.
Conclusions:
- NK cells directly limit CVB3m replication by killing infected host cells.
- This study provides direct evidence for NK cell-mediated antiviral immunity against CVB3m.
- NK cells represent a potential therapeutic target for viral myocarditis.